Adjuvant chemotherapy for surgically resected non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 144, Issue 3, 2012, Pages

  Heon, Stephanie ^a,b,c   Johnson, Bruce E ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ETOPOSIDE; MONOCLONAL ANTIBODY; NAVELBINE; PACLITAXEL; VINBLASTINE; VINDESINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL ASSESSMENT; DRUG EFFICACY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 84865681882     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.03.039     Document Type: Editorial

References (19)

1. P. Goldstraw, J. Crowley, K. Chansky, D.J. Giroux, P.A. Groome, and R. Rami-Porta The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706 714
2. Non-small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials BMJ 311 1995 899 909
3. H. Kato, Y. Ichinose, M. Ohta, E. Hata, N. Tsubota, and H. Tada A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung N Engl J Med 350 2004 1713 1721
4. R. Arriagada, B. Bergman, A. Dunant, T. Le Chevalier, J.P. Pignon, and J. Vansteenkiste Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360
5. R. Arriagada, A. Dunant, J.P. Pignon, B. Bergman, M. Chabowski, and D. Grunenwald Long-term results of the international adjuvant lung cancer trial evaluating adjuvant cisplatin-based chemotherapy in resected lung cancer J Clin Oncol 28 2010 35 42
6. T. Winton, R. Livingston, D. Johnson, J. Rigas, M. Johnston, and C. Butts Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2005 2589 2597
7. C.A. Butts, K. Ding, L. Seymour, P. Twumasi-Ankrah, B. Graham, and D. Gandara Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10 J Clin Oncol 28 2010 29 34
8. J.Y. Douillard, R. Rosell, M. De Lena, F. Carpagnano, R. Ramlau, and J.L. Gonzales-Larriba Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 2006 719 727
9. G.V. Scagliotti, R. Fossati, V. Torri, L. Crino, G. Giaccone, and G. Silvano Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer J Natl Cancer Inst 95 2003 1453 1461
10. D. Waller, M.D. Peake, R.J. Stephens, N.H. Gower, R. Milroy, and M.K. Parmar Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial Eur J Cardiothorac Surg 26 2004 173 182
11. G.M. Strauss, J.E. Herndon II, M.A. Maddaus, D.W. Johnstone, E.A. Johnson, and D.H. Harpole Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups J Clin Oncol 26 2008 5043 5051
12. A. Ardizzoni, L. Boni, M. Tiseo, F.V. Fossella, J.H. Schiller, and M. Paesmans Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis J Natl Cancer Inst 99 2007 847 857
13. J.P. Pignon, H. Tribodet, G.V. Scagliotti, J.Y. Douillard, F.A. Shepherd, and R.J. Stephens Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552 3559
14. L.A. Stewart, S. Burdett, J.F. Tierney, J. Pignon NSCLC Collaborative Group Surgery and adjuvant chemotherapy (CT) compared to surgery alone in non-small cell lung cancer (NSCLC): a meta-analysis using individual patient data (IPD) from randomized clinical trials (RCT) ASCO Meeting Abstracts 25 2007 7552
15. K.M. Pisters, W.K. Evans, C.G. Azzoli, M.G. Kris, C.A. Smith, and C.E. Desch Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline J Clin Oncol 25 2007 5506 5518
16. J. Yoshida, K. Nagai, H. Asamura, T. Goya, Y. Koshiishi, and Y. Sohara Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database J Thorac Oncol 4 2009 959 963
17. P. Bonnette, P. Puyo, C. Gabriel, R. Giudicelli, J.F. Regnard, and M. Riquet Surgical management of non-small cell lung cancer with synchronous brain metastases Chest 119 2001 1469 1475
18. T. Tanvetyanon, L.A. Robinson, M.J. Schell, V.E. Strong, R. Kapoor, and D.G. Coit Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis J Clin Oncol 26 2008 1142 1147
19. P.S. Billing, D.L. Miller, M.S. Allen, C. Deschamps, V.F. Trastek, and P.C. Pairolero Surgical treatment of primary lung cancer with synchronous brain metastases J Thorac Cardiovasc Surg 122 2001 548 553